[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352366-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352366-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeted-metabolism-creates-possibilities-for-lung-cancer-treatment-in-the-precision-tumor-era","Targeted metabolism creates possibilities for lung cancer treatment in the precision tumor era","","Lung cancer is the leading cause of cancer-related mortality worldwide, and outcomes remain poor despite molecular targeted therapy and immunotherapy advances. In the precision medicine era, tumor metabolic reprogramming is increasingly recognized as a key driver of lung cancer initiation and progression. Preclinical evidence supports targeting metabolic pathways to open new research and therapeutic opportunities. This review synthesizes recent findings on glucose, lipid, protein, and nucleotide metabolism, linking pathway regulation to pathogenesis and evaluating their potential as treatment targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeted-metabolism-creates-possibilities-for-lung-cancer-treatment-in-the-precision-tumor-era/352366/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeted-metabolism-creates-possibilities-for-lung-cancer-treatment-in-the-precision-tumor-era/352366.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is lung cancer treatment still challenging despite targeted therapy and immunotherapy?","Question",{"text":63,"@type":64},"Overall prognosis remains poor, and many patients are diagnosed at an advanced stage, where combined strategies often extend survival without achieving cure.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does metabolic reprogramming play in lung cancer?",{"text":68,"@type":64},"Metabolic reprogramming remodels carbohydrate, lipid, amino acid, and nucleotide metabolism to support proliferation and adaptation to nutrient-deprived environments.",{"name":70,"@type":61,"acceptedAnswer":71},"Which metabolism categories does the review cover for therapeutic targeting?",{"text":72,"@type":64},"The review summarizes research on glucose metabolism, lipid metabolism, protein metabolism, and nucleotide metabolism in lung cancer, and evaluates these pathways as potential therapeutic targets.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352366,1791424443,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Huang et al. Respiratory Research (2026) 27:55 [https://doi.org/10.1186/s12931-025-03383-7](https://doi.org/10.1186/s12931-025-03383-7)  \nRespiratory Research  \nREVIEW Open Access  \nTargeted metabolism creates possibilities for lung cancer treatment in the precision tumor era  \nXing Huang1†, Huimin Shen1†, Chenglong Shao1†, Lei Wang2, Xinying Zheng1, Yu Wang1, Lei Qiu1, Shaoyan Zhang1, Tong Zhang3* and Zhenhui Lu 1*  \nAbstract  \nLung cancer has emerged as the primary cause of cancer-related deaths worldwide, and advances in its treatment are critically needed. Despite significant breakthroughs in molecular targeted therapy and immunotherapy in lung cancer, the overall prognosis for patients remains poor. In the era of precision medicine, the pivotal role of tumor metabolic reprogramming in the onset and progression of lung cancer has become increasingly evident. Preclinical studies have demonstrated the potential efficacy of targeting tumor metabolic pathways, thereby suggesting new avenues for lung cancer treatment research. A comprehensive understanding of the regulatory mechanisms underlying these metabolic pathways could hold potential for developing innovative therapies and improving patient outcomes in the future. This review summarizes the latest research in glucose metabolism, lipid metabolism, protein metabolism, and nucleotide metabolism in lung cancer. It further examines the role these metabolic pathways play in lung cancer pathogenesis and explores their potential as therapeutic targets. Keywords Lung cancer, Metabolic reprogramming, Targeted therapy, Precision medicine, Tumor microenvironment  \n†Xing Huang, Huimin Shen and Chenglong Shao contributed equally to this work and first authors.  \n*Correspondence:  \nTong Zhang [zhangtongshutcm@hotmail.com](zhangtongshutcm@hotmail.com)[ ](zhangtongshutcm@hotmail.com)Zhenhui Lu [Dr_luzh@shutcm.edu.cn](Dr_luzh@shutcm.edu.cn)  \n1Institute of Respiratory Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \n2Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \n3College of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \nIntroduction  \nIn 2022, lung cancer emerged as the most common cancer type with nearly 2.5 million new cases (accounting for 1/8 of global new cancer cases), and ranked first in mortality with 1.8 million deaths (18.7% of total cancer deaths), significantly surpassing colorectal cancer (9.3%) in second place [1]. Although the overall 5-year survival rate for lung cancer is only 20%, the survival rate for early-stage (I-II) patients can reach 60%, while it drops sharply to 6% for advanced-stage (IV) patients [2]. In recent years, the annual decline in lung cancer mortality increased from 3.1% during 2005–2014 to 5.3% during 2014–2020, benefiting from advancements in diagnostic and treatment methods [3]. For instance, stereotactic body radiotherapy and adjuvant chemotherapy have significantly improved the prognosis of early-stage patients, while locally advanced patients have benefited from  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation","cbCaicyg0titlcQO","https://ap.wps.com/l/cbCaicyg0titlcQO","pdf",3510031,28,"English","# Abstract\n## Introduction","[{\"question\":\"Why is lung cancer treatment still challenging despite targeted therapy and immunotherapy?\",\"answer\":\"Overall prognosis remains poor, and many patients are diagnosed at an advanced stage, where combined strategies often extend survival without achieving cure.\"},{\"question\":\"What role does metabolic reprogramming play in lung cancer?\",\"answer\":\"Metabolic reprogramming remodels carbohydrate, lipid, amino acid, and nucleotide metabolism to support proliferation and adaptation to nutrient-deprived environments.\"},{\"question\":\"Which metabolism categories does the review cover for therapeutic targeting?\",\"answer\":\"The review summarizes research on glucose metabolism, lipid metabolism, protein metabolism, and nucleotide metabolism in lung cancer, and evaluates these pathways as potential therapeutic targets.\"}]","Targeted metabolism creates possibilities for lung cancer treatment in the precision tumor era | PDF",1790099239,71,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8173fde5794ff82870535b00e61f138.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce2ed9667d2b7430d135d80f6c4745cf.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd10879dc6ae14d4b7ceda0db1bd4035.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b47da8a5b8cb95544092e29f0627023d.webp",980,1306]